Pfam Domains GO Terms
| Ifi-6-16 |
| negative regulation of mitochondrial depolarization |
| negative regulation of membrane depolarization |
| regulation of mitochondrial depolarization |
| release of cytochrome c from mitochondria |
| cellular response to virus |
| negative regulation of signal transduction in absence of ligand |
| negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| regulation of membrane depolarization |
| regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| apoptotic mitochondrial changes |
| type I interferon signaling pathway |
| cellular response to type I interferon |
| regulation of mitochondrial membrane potential |
| response to type I interferon |
| negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| regulation of epidermal growth factor receptor signaling pathway |
| negative regulation of cysteine-type endopeptidase activity |
| regulation of ERBB signaling pathway |
| negative regulation of extrinsic apoptotic signaling pathway |
| mitochondrial membrane |
| reactive oxygen species metabolic process |
| intrinsic apoptotic signaling pathway |
| regulation of extrinsic apoptotic signaling pathway |
| defense response to virus |
| regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| negative regulation of apoptotic signaling pathway |
| regulation of cysteine-type endopeptidase activity |
| negative regulation of endopeptidase activity |
| negative regulation of peptidase activity |
| response to virus |
| apoptotic signaling pathway |
| negative regulation of proteolysis |
| mitochondrial inner membrane |
| regulation of apoptotic signaling pathway |
| regulation of endopeptidase activity |
| regulation of membrane potential |
| mitochondrion organization |
| regulation of peptidase activity |
| negative regulation of hydrolase activity |
| cytokine-mediated signaling pathway |
| regulation of proteolysis |
| innate immune response |
| ion homeostasis |
| negative regulation of catalytic activity |
| negative regulation of apoptotic process |
| negative regulation of programmed cell death |
| apoptotic process |
| defense response to other organism |
| negative regulation of cell death |
| cellular response to cytokine stimulus |
| negative regulation of cellular protein metabolic process |
| programmed cell death |
| immune effector process |
| cell death |
| response to cytokine |
| negative regulation of protein metabolic process |
| chemical homeostasis |
| negative regulation of molecular function |
| mitochondrion |
| negative regulation of signal transduction |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| defense response |
| negative regulation of cell communication |
| negative regulation of signaling |
| regulation of apoptotic process |
| regulation of programmed cell death |
| negative regulation of response to stimulus |
| homeostatic process |
| regulation of cell death |
| intracellular signal transduction |
| immune response |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution